The reduced folate carrier (RFC) mRNA expression in urothelial and non-urothelial bladder carcinomas /
Alyaa Mahmoud Abdelhaleem
The reduced folate carrier (RFC) mRNA expression in urothelial and non-urothelial bladder carcinomas / Alyaa Mahmoud Abdelhaleem ; Supervised Laila Mahran , Hilde Spahn-Langguth , Khaled Abou-Aisha - Cairo : Alyaa Mahmoud Abdelhaleem , 2010 - 139Leaves : charts , facsimiles ; 30cm
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmacology and Toxicology
Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence . The majority (77%) of bladder tumours occur in men . It is the seventh most common malignancy in men and seventeenth in women² . The spectrum of bladder tumours is broad and includes urothelial (transitional) cell carcinoma (TCC) and non-urothelial carcinoma (squamous cell carcinoma [SCC] and adenocarcinoma)
The reduced folate carrier (RFC) mRNA expression in urothelial and non-urothelial bladder carcinomas / Alyaa Mahmoud Abdelhaleem ; Supervised Laila Mahran , Hilde Spahn-Langguth , Khaled Abou-Aisha - Cairo : Alyaa Mahmoud Abdelhaleem , 2010 - 139Leaves : charts , facsimiles ; 30cm
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmacology and Toxicology
Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence . The majority (77%) of bladder tumours occur in men . It is the seventh most common malignancy in men and seventeenth in women² . The spectrum of bladder tumours is broad and includes urothelial (transitional) cell carcinoma (TCC) and non-urothelial carcinoma (squamous cell carcinoma [SCC] and adenocarcinoma)